International Circuit EMA recommends Novavax Covid vax for adolescents June 24, 2022 The advisory committee to the European Union’s drug regulator on Thursday recommended expanding the use of Novavax Inc’s Covid-19 vaccine for adolescents aged 12 to 17 years. Reuters Related Topics: Up Next US allows commercial labs to test for monkeypox Don't Miss Enugu collaborates with NSIA